Sheila Olson

  • • 20+ years experience as a health IT executive and entrepreneur
  • • 25 years as an active trader, specializing in both fundamental and technical analysis
  • • Currently writes about investing, personal, and business finance topics for both consumers and financial professionals

 

Experience

As a health IT entrepreneur and business owner for over 20 years, Sheila worked with leading edge technology companies and visionaries in the health care field. She began writing about trends in health care and biotechnology in the 1990s, as well as public policy and regulations that affected the industry, for trade publications.

Sheila has been active in the markets for over two decades; her business background and health care focus shapes her analytical approach to stocks and opportunities. She is especially interested in emerging technology and growth potential in biotechnology and pharmaceuticals.

She currently writes about investing, especially fundamentals and technical analysis, for Investopedia and the Motley Fool, among others, and on personal finance issues for major financial brands such as Prudential.

Education

Sheila earned a bachelor's degree in public health from Northern Arizona University, and a Bachelor of Arts degree in English from Augustana University.

Quote from Sheila

"Investing is an important skill—I love the market—but my true passion is financial literacy, helping people understand money as a tool they can leverage to achieve their personal goals."

Investopedia and Dotdash

Investopedia helps you understand complex financial concepts, learn and improve your investing skills, and learn how to manage your money. Whether you’re in a classroom, a boardroom or your living room, our editors and network of financial advisors and experts have answered your questions and proudly earned your trust since 1999. Investopedia is part of Dotdash, a collection of some of the web’s largest and most trusted digital media brands.

  • Showing 76-82 of 82 items
  • <<
  • ...
  • 4
  • 5
  • 6
  1. Company Insights

    Anadarko Eyes Expansion in Midland (APC)

    The company looks to ramp up production in the Delaware and DJ basins with cash from its Freeport-McMoRan deal.
  2. Company Insights

    Baytex Short Interest Surges in September (BTE)

    A sharp spike in short interest last month may signal bearish sentiment on this Canadian oil and gas producer.
  3. Company Insights

    What CytRx Latest Trial Results Really Mean (CYTR)

    The company’s ESMO presentation gives insight into latest analyst recommendations, offers potential for cautious optimism ...
  4. Big Data

    Competition Fuels Aetna, Merck Deal (AET, MRK)

    In an effort to boost sales of its diabetes drugs, Merck inks value-based contract to ensure preferred status with insurance ...
  5. Company Insights

    How Bad Is Baytex Debt? (BTE)

    Improved capital efficiency and a potential uptick in oil prices shed new light on the company’s $1.9 billion in debt.
  6. Company Insights

    Firdapse Fuels Catalyst Pharmaceutical's Gains (CPRX)

    Significant findings in phase 3 clinical trials suggest FDA approval is imminent, buoying investor confidence.
  7. Company Insights

    Chesapeake Energy Hit with Class Action Lawsuit (CHK)

    Suit alleges DOJ subpoenas over potentially improper accounting procedures caused decline in share value.
  • Showing 76-82 of 82 items
  • <<
  • ...
  • 4
  • 5
  • 6